Toxoplasma vaccines: appropriate end points and sample size in future human clinical trials

Expert Rev Anti Infect Ther. 2009 Oct;7(8):905-8. doi: 10.1586/eri.09.81.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Adolescent
  • Adult
  • Animals
  • Child
  • Child, Preschool
  • Clinical Trials as Topic / standards*
  • Endpoint Determination / standards*
  • Humans
  • Infant
  • Protozoan Vaccines*
  • Sample Size
  • Toxoplasma / immunology*
  • Toxoplasmosis, Ocular / parasitology
  • Toxoplasmosis, Ocular / prevention & control*

Substances

  • Protozoan Vaccines